Next Article in Journal
A Review of SARS-CoV-2 and the Ongoing Clinical Trials
Next Article in Special Issue
All d-Lysine Analogues of the Antimicrobial Peptide HPA3NT3-A2 Increased Serum Stability and without Drug Resistance
Previous Article in Journal
The Interactions between the Antimicrobial Peptide P-113 and Living Candida albicans Cells Shed Light on Mechanisms of Antifungal Activity and Resistance
Article

A Novel Ruthenium Based Coordination Compound Against Pathogenic Bacteria

1
Department of Chemistry and Biochemistry, Faculty of AgriSciences, Mendel University in Brno, CZ-613 00 Brno, Czech Republic
2
Central European Institute of Technology, Brno University of Technology, CZ-61200 Brno, Czech Republic
3
Department of Inorganic Chemistry, Faculty of Science, Palacky University, CZ-771 46 Olomouc, Czech Republic
4
Global Change Research Institute of the Czech Academy of Sciences, CZ- 603 00 Brno, Czech Republic
*
Authors to whom correspondence should be addressed.
Int. J. Mol. Sci. 2020, 21(7), 2656; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21072656
Received: 10 March 2020 / Revised: 6 April 2020 / Accepted: 7 April 2020 / Published: 10 April 2020
The current epidemic of antibiotic-resistant infections urges to develop alternatives to less-effective antibiotics. To assess anti-bacterial potential, a novel coordinate compound (RU-S4) was synthesized using ruthenium-Schiff base-benzimidazole ligand, where ruthenium chloride was used as the central atom. RU-S4 was characterized by scanning electron microscope (SEM), energy-dispersive X-ray spectroscopy (EDS), and Raman spectroscopy. Antibacterial effect of RU-S4 was studied against Staphylococcus aureus (NCTC 8511), vancomycin-resistant Staphylococcus aureus (VRSA) (CCM 1767), methicillin-resistant Staphylococcus aureus (MRSA) (ST239: SCCmecIIIA), and hospital isolate Staphylococcus epidermidis. The antibacterial activity of RU-S4 was checked by growth curve analysis and the outcome was supported by optical microscopy imaging and fluorescence LIVE/DEAD cell imaging. In vivo (balb/c mice) infection model prepared with VRSA (CCM 1767) and treated with RU-S4. In our experimental conditions, all infected mice were cured. The interaction of coordination compound with bacterial cells were further confirmed by cryo-scanning electron microscope (Cryo-SEM). RU-S4 was completely non-toxic against mammalian cells and in mice and subsequently treated with synthesized RU-S4. View Full-Text
Keywords: coordination compound; antimicrobial compound; ruthenium; benzimidazole; SEM; EDS coordination compound; antimicrobial compound; ruthenium; benzimidazole; SEM; EDS
Show Figures

Figure 1

MDPI and ACS Style

Sur, V.P.; Mazumdar, A.; Kopel, P.; Mukherjee, S.; Vítek, P.; Michalkova, H.; Vaculovičová, M.; Moulick, A. A Novel Ruthenium Based Coordination Compound Against Pathogenic Bacteria. Int. J. Mol. Sci. 2020, 21, 2656. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21072656

AMA Style

Sur VP, Mazumdar A, Kopel P, Mukherjee S, Vítek P, Michalkova H, Vaculovičová M, Moulick A. A Novel Ruthenium Based Coordination Compound Against Pathogenic Bacteria. International Journal of Molecular Sciences. 2020; 21(7):2656. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21072656

Chicago/Turabian Style

Sur, Vishma P.; Mazumdar, Aninda; Kopel, Pavel; Mukherjee, Soumajit; Vítek, Petr; Michalkova, Hana; Vaculovičová, Markéta; Moulick, Amitava. 2020. "A Novel Ruthenium Based Coordination Compound Against Pathogenic Bacteria" Int. J. Mol. Sci. 21, no. 7: 2656. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21072656

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop